Showing 1 - 10 of 69
In this Q&A, Jenny Yu, the Industry Practice Leader for Chemicals and Life Sciences in the UK at Marsh & McLennan shares her thoughts on the impact of COVID-19 on the life sciences sector.
We attended a variety of virtual sessions over four days of ACRM 2020, including seminars, panel debates and product exhibitions from a diverse range of institutions, clinicians and entrepreneurs.
This year’s American Congress of Rehabilitation Medicine annual conference was itself an example of technological improvisation, with virtual delegates attending online due to the pandemic. One of the recurring themes of its numerous seminars was the medical necessity for reinvention of traditional rehabilitation models and the involuntary shift of providers towards caretech solutions for reasons of business continuity and infection control.
Opioid addiction has received growing publicity in the US in recent years, with hundreds of thousands affected. Despite regulatory changes the problem remains significant, to the extent that the issue has featured in the 2020 race for the White House.
The American Congress of Rehabilitation Medicine 2020 annual conference featured several limb loss or amputation-focused presentations. Many of these highlighted a new approach that is developing in the US, where the sector as a whole collaborates on accessible platforms with the aim of sharing information and resources so as to improve treatment and quality of life for amputees.
We are pleased to announce that the publication of the 2021 edition of The Legal 500 UK has seen us ranked as a ‘top-tier firm’ in nine practice areas.
When countries with well-developed health systems scrambled to purchase life-saving ventilators at the start of the COVID-19 crisis it illustrated just how serious the pandemic would be. Working on a war footing, governments from France to Germany, the UK and the US asked industry to produce ventilators and personal protective equipment at speed.
Best practice is slipping in clinical trials as the scientific community races to respond to Covid-19. Chubb and Kennedys consider the risks that are emerging as a result and how they can be mitigated.
In July, the European Commission released a Communication ahead of the end of the Brexit transition period. The paper’s wordy, but instructive, title is: “Getting ready for changes: Communication on readiness at the end of the transition period between the European Union and the United Kingdom”.
Historically, difficulties in proving a causal link between air pollution and poor health have kept at bay pollution related claims and governments’ accountability. However, this may be about to change.